Is either Argireline or Matrixyl FDA-approved?

No. Argireline is sold as a cosmetic skin-care ingredient, not an injectable drug. Matrixyl is sold as a cosmetic skincare ingredient.

Which has stronger human evidence, Argireline or Matrixyl?

Neither clearly. Both have human clinical data. The key source for Argireline is Wang, J Cosmet Laser Ther 2013; for Matrixyl, it is Robinson, Int J Cosmet Sci 2005.

What are the main safety concerns with Argireline and Matrixyl?

Argireline has a benign cosmetic track record; localized skin irritation is the usual complaint. Matrixyl has a benign record as a cosmetic; occasional local skin irritation.

Head-to-head

Argireline vs Matrixyl

Same shelf, opposite mechanisms: one tries to quiet the muscle that folds the skin, the other tries to tell fibroblasts to rebuild what folding wore away.

By Julian RothResearch & dataUpdated October 2026

Short answer

Argireline and Matrixyl are both marketed for topical anti-wrinkle use and both have human clinical data, so the difference is in how they work and what their trials found. The headline human result for Argireline is 48.9 percent total anti-wrinkle efficiency in a four-week randomized placebo-controlled trial of 60 subjects using it twice daily.

Argireline

Acetyl hexapeptide-8

Clinical data

A topical peptide that mimics SNAP-25 (botulinum's target) to soften expression lines; small trials show a modest wrinkle effect, but penetration is limited and it is not equivalent to injected Botox.

Full Argireline evidence review

Matrixyl

Palmitoyl pentapeptide-4

Clinical data

A matrikine that signals fibroblasts to make collagen; small split-face trials show a modest wrinkle effect, but the evidence is thin, industry-linked and formulation-dependent.

Full Matrixyl evidence review

Argireline vs Matrixyl: head to head

FDA status / approved use: Argireline
Sold as a cosmetic skin-care ingredient, not an injectable drug
Matrixyl
Sold as a cosmetic skincare ingredient
Marketed for: Argireline
Topical anti-wrinkle
Matrixyl
Topical anti-wrinkle
Outcome areas: Argireline
Skin / hair
Matrixyl
Skin / hair
Evidence grade: Argireline
Clinical data
Matrixyl
Clinical data
How it works: Argireline
Mimics SNAP-25 to dampen the nerve signals that contract facial muscles
Matrixyl
Collagen fragment that signals skin fibroblasts to make more collagen
Route and dosing: Argireline
Topical serum or cream applied to the skin
Matrixyl
Topical cream applied to the skin
Headline human result: Argireline
48.9 percent total anti-wrinkle efficiency in a four-week randomized placebo-controlled trial of 60 subjects using it twice daily
Matrixyl
Modest improvement in wrinkles and fine lines vs the untreated side in a 12-week split-face trial of 93 women
Strongest evidence: Argireline
Wang, J Cosmet Laser Ther 2013Argireline evidence reviewPubMed 23607739
Matrixyl
Robinson, Int J Cosmet Sci 2005Matrixyl evidence reviewPubMed 18492182
Key safety signal: Argireline
Benign cosmetic track record; localized skin irritation is the usual complaint
Matrixyl
Benign record as a cosmetic; occasional local skin irritation
How it is obtained: Argireline
Sold in cosmetic skin-care products
Matrixyl
Sold in cosmetic skin-care products

	Argireline	Matrixyl
FDA status / approved use	Sold as a cosmetic skin-care ingredient, not an injectable drug	Sold as a cosmetic skincare ingredient
Marketed for	Topical anti-wrinkle	Topical anti-wrinkle
Outcome areas	Skin / hair	Skin / hair
Evidence grade	Clinical data	Clinical data
How it works	Mimics SNAP-25 to dampen the nerve signals that contract facial muscles	Collagen fragment that signals skin fibroblasts to make more collagen
Route and dosing	Topical serum or cream applied to the skin	Topical cream applied to the skin
Headline human result	48.9 percent total anti-wrinkle efficiency in a four-week randomized placebo-controlled trial of 60 subjects using it twice daily	Modest improvement in wrinkles and fine lines vs the untreated side in a 12-week split-face trial of 93 women
Strongest evidence	Wang, J Cosmet Laser Ther 2013Argireline evidence reviewPubMed 23607739	Robinson, Int J Cosmet Sci 2005Matrixyl evidence reviewPubMed 18492182
Key safety signal	Benign cosmetic track record; localized skin irritation is the usual complaint	Benign record as a cosmetic; occasional local skin irritation
How it is obtained	Sold in cosmetic skin-care products	Sold in cosmetic skin-care products

marks a row where the two differ. “Not established” marks a cell the available evidence does not answer. Evidence grades come from our evidence matrix, which grades each molecule on the human data for the use it is marketed for.

Clinical data:: Tested in humans — but investigational, discontinued, or proven only on a surrogate marker (not the marketed outcome).

Our verdict

Both are real cosmetic ingredients with small effects, and they target different kinds of lines. Argireline mimics the N-terminus of SNAP-25 to interfere with neurotransmitter release and soften the contractions behind expression wrinkles; small, largely manufacturer-linked studies show measurable but modest reductions in wrinkle depth, and in vitro penetration work found only a small fraction of applied peptide crosses the skin. Matrixyl works as a collagen-derived matrikine signaling fibroblasts, with small split-face trials showing modest smoothing, again mostly from the ingredient's commercial orbit. No study has compared them head-to-head, results for both hinge on formulation, and Argireline is not equivalent to injected botulinum toxin.

Argireline fits if

Someone whose concern is dynamic expression lines and who wants a low-risk daily serum, with expectations set to gentle softening rather than anything resembling an injection.

Matrixyl fits if

Someone focused on fine lines and general photoaged texture who wants a well-tolerated peptide to sit alongside a retinoid, not replace it.

Argireline vs Matrixyl: common questions

Is either Argireline or Matrixyl FDA-approved?: No. Argireline is sold as a cosmetic skin-care ingredient, not an injectable drug. Matrixyl is sold as a cosmetic skincare ingredient.
Which has stronger human evidence, Argireline or Matrixyl?: Neither clearly. Both have human clinical data. The key source for Argireline is Wang, J Cosmet Laser Ther 2013; for Matrixyl, it is Robinson, Int J Cosmet Sci 2005.
What are the main safety concerns with Argireline and Matrixyl?: Argireline has a benign cosmetic track record; localized skin irritation is the usual complaint. Matrixyl has a benign record as a cosmetic; occasional local skin irritation.

Key studies behind each

Argireline

Blanes-Mira C, Clemente J, Jodas G, et al. (2002). A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci. PubMed 18498523
Wang Y, Wang M, Xiao S, et al. (2013). The anti-wrinkle efficacy of synthetic hexapeptide (Argireline) in Chinese subjects. J Cosmet Laser Ther. PubMed 23607739
Kraeling ME, Zhou W, Wang P, Ogunsola OA. (2015). In vitro skin penetration of acetyl hexapeptide-8 from a cosmetic formulation. Cutan Ocul Toxicol. PubMed 24754410
Hoppel M, Mahrhauser D, Stallinger C, et al. (2015). Topical delivery of acetyl hexapeptide-8 from different emulsions. Eur J Pharm Sci. PubMed 25497319

Matrixyl

Katayama K, Armendariz-Borunda J, Raghow R, et al. (1993). A pentapeptide from type I procollagen promotes extracellular matrix production. J Biol Chem. PubMed 8486721
Robinson LR, Fitzgerald NC, Doughty DG, et al. (2005). Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci. PubMed 18492182
Gorouhi F, Maibach HI. (2009). Role of topical peptides in preventing or treating aged skin. Int J Cosmet Sci. PubMed 19570099
Mohammed YH, Yamada M, Lin LL, et al. (2014). Microneedle enhanced delivery of cosmeceutically relevant peptides in human skin. PLoS One. PubMed 25033398

The full evidence reviews

Argireline: what the evidence says about “Botox in a bottle”
Acetyl hexapeptide-8 borrows botulinum toxin’s SNAP-25 target to soften expression lines topically — the mechanism is real, the human effect is modest, and it is not an injection.
Updated August 2026
Matrixyl: what the evidence says about the “collagen-boosting” peptide
Palmitoyl pentapeptide-4 (pal-KTTKS) is a collagen fragment that signals fibroblasts to make more matrix — the mechanism is real, the topical trials are small and modest, and it sits beside retinoids, not above them.
Updated August 2026

Where to get it

Where to get peptide therapy

Clinician-led telehealth services that prescribe compounded peptides. The specific peptides offered vary by provider — confirm Argireline (Acetyl Hexapeptide-8) availability before ordering.

Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.

Compare all 204 peptide-therapy providers →

Provider reviews we publish: Nova MDNu Image MedicalNucificNucore HealthNuform HealthNäky

Related comparisons

GHK-Cu vs Matrixyl